Robotic Brachytherapy and Sublobar Resection for T1 Non-Small Cell Lung Cancer in High-Risk Patients

被引:6
|
作者
Blasberg, Justin D. [1 ]
Belsley, Scott J.
Schwartz, Gary S.
Evans, Andrew
Wernick, Iddo
Ashton, Robert C., Jr.
Bhora, Faiz Y.
Connery, Cliff P.
机构
[1] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Dept Surg, New York, NY 10023 USA
来源
ANNALS OF THORACIC SURGERY | 2010年 / 89卷 / 02期
关键词
THORACOSCOPIC WEDGE RESECTION; LIMITED RESECTION; I-125; BRACHYTHERAPY; LOBECTOMY; SEGMENTECTOMY; CARCINOMA; PULMONARY; SURVIVAL; IMPLANTATION;
D O I
10.1016/j.athoracsur.2009.09.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Sublobar lung resection and brachytherapy seed placement is gaining acceptance for T1 non-small cell lung cancer (NSCLC) in select patients with comorbidities precluding lobectomy. Our institution first reported utilization of the da Vinci system for robotic brachytherapy developed experimentally in swine and applied to high-risk patients 5 years ago. We now report seed dosimetrics and midterm follow-up. Methods. Eleven high-risk patients with stage IA NSCLC who were not candidates for conventional lobectomy underwent limited resection of 12 primary tumors. To reduce locoregional recurrence, I-125 brachytherapy seeds were robotically sutured intracorporeally over resection margins to deliver 14,400 cGy 1 cm from the implant plane. Patients were followed with dosimetric computed tomography scans at 30 +/- 16 days. Survival and sites of recurrence were documented. Results. Resected tumor size averaged 1.48 +/- 0.38 cm (range, 1.1 to 2.1 cm). Perioperative mortality was 0% and recurrence was 9% (1 of 11 [margin recurrence at 6 months with resultant mortality at 1 year]). Follow-up duration was 31.82 +/- 17.35 months. Dosimetrics confirmed 14,400 cGy delivery using 24.21 +/- 4.6 I-125 seeds (range, 17 to 30 seeds) over a planning target volume of 10.29 +/- 2.39 cc(3). Overall, 84.1% of the planning target volume was covered by 100% of the prescription dose (V100), and 88.2% was covered by 87% of the prescription dose (V87), comparable to open dosimetric data at our institution. Follow-up imaging confirmed seed stability in all patients. Conclusions. Robotic I-125 brachytherapy seed placement is a feasible adjuvant procedure to reduce the incidence of recurrence after sublobar resection in medically compromised patients. Tailored robotic seed placement delivers an exact dosing regimen in a minimally invasive fashion with equivalent precision to open surgery. (Ann Thorac Surg 2010;89:360-7) (C) 2010 by The Society of Thoracic Surgeons
引用
收藏
页码:360 / 367
页数:8
相关论文
共 50 条
  • [41] Sublobar resection is not always superior for early-stage lung cancer in high-risk patients
    Fukui, Mariko
    Matsunaga, Takeshi
    Hattori, Aritoshi
    Takamochi, Kazuya
    Nojiri, Shuko
    Suzuki, Kenji
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (01)
  • [42] Meta-analysis of Lobectomy and Sublobar Resection for Stage I Non-small Cell Lung Cancer
    Li, Jialong
    Wang, Yan
    Li, Jue
    Cao, Shangqi
    Che, Guowei
    CLINICAL LUNG CANCER, 2022, 23 (03) : 208 - 213
  • [43] Sublobar Resection of Non-Small-Cell Lung Cancer: Wedge Resection vs. Segmentectomy
    Yu, Kyeong Ri
    Julliard, Walker A.
    CURRENT ONCOLOGY, 2024, 31 (05) : 2497 - 2507
  • [44] Thoracoscopic Lobectomy Versus Sublobar Resection for pStage I Geriatric Non-Small Cell Lung Cancer
    Lin, Young-Jen
    Chiang, Xu-Heng
    Lu, Tzu-Pin
    Hsieh, Min-Shu
    Lin, Mong-Wei
    Hsu, Hsao-Hsun
    Chen, Jin-Shing
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [45] Prognostic impact of lymphadenectomy on outcomes of sublobar resection for non-small cell lung cancer ≤ 1 or >1 to 2 cm
    Zheng, Enkuo
    Yang, Minglei
    Li, Rui
    Ni, Junjun
    Xu, Xiang
    Zhao, Guofang
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2049 - +
  • [46] Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection
    Yendamuri, Sai
    Dhillon, Samjot Singh
    Groman, Adrienne
    Dy, Grace
    Dexter, Elisabeth
    Picone, Anthony
    Nwogu, Chukwumere
    Demmy, Todd
    Hennon, Mark
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (01): : 394 - 402
  • [47] Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis
    Gu, Chang
    Wang, Rui
    Pan, Xufeng
    Huang, Qingyuan
    Zhang, Yangyang
    Yang, Jun
    Shi, Jianxin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (11) : 2375 - 2382
  • [48] Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer
    Lv, Xiayi
    Cao, Jinlin
    Dai, Xiaona
    Rusidanmu, Aizemaiti
    THORACIC CANCER, 2018, 9 (08) : 1026 - 1031
  • [49] The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection
    Choi, Si Young
    Moon, Mi Hyoung
    Moon, Youngkyu
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6431 - 6443
  • [50] Outcomes of Completion Lobectomy for Locoregional Recurrence after Sublobar Resection in Patients with Non-small Cell Lung Cancer
    Lee, Cho Eun
    Yun, Jeonghee
    Jeon, Yeong Jeong
    Lee, Junghee
    Park, Seong Yong
    Cho, Jong Ho
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Jhingook
    Shim, Young Mog
    JOURNAL OF CHEST SURGERY, 2024, 57 (02): : 128 - 135